TwitterLinkedInYoutubeSlideshareflickrIFPMA - Global Health Matters - BlogRSS
IFPMA Home

International Federation of Pharmaceutical Manufacturers & Associations



© Eli Lilly



Putting NCDs into Focus

04 February 2013, Geneva

Non-communicable diseases (NCDs) – cancer, heart disease, diabetes, and chronic respiratory disease among others - are leading causes of death worldwide. An estimated 36 million people die from such diseases each year. With 80% of these fatalities occurring in low- and middle-income countries, the
disease burden is particularly heavy and increasing quickly.
Cost-effective interventions are available and, through sustained policy action by the health community, can help prevent millions of deaths among people already afflicted. To prevent or reduce disease burden in others, programs are available to manage risk factors due to lifestyle or genetics.

The IFPMA invites you to the first Geneva Pharma Forum of 2013 for a moderated discussion featuring a distinguished set of experts. On this occasion, the Johns Hopkins Institute for Applied Economics, Global Health and the Study of Business Enterprise will launch a new set of policy briefs collectively titled “Addressing the Gaps in Global Policy and Research for Non-Communicable Diseases.” The authors comprise leading scholars who analyzed gaps in NCD research, policy and practice to make actionable recommendations to close the gaps.

Photo Gallery